Our Sponsors

Our sponsors include national and international organizations. We deeply appreciate their support – World Sepsis Day would not be possible without them. Please note that sponsors do not influence the planning and execution of World Sepsis Day in any way.

Gold Sponsors

Sanofi

Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives. We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world. 

 

Masimo

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, and patient monitors. Masimo is one of the main partners and supporters of the Global Sepsis Innovation Platform (GSIP), launched by the Global Sepsis Alliance in February 2025.

Silver Sponsors

bioMérieux

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide.

 

ThermoFisher Scientific

Thermo Fisher Scientific is the world leader in serving science. Their mission is to enable their customers to make the world healthier, cleaner, and safer. 

Bronze Sponsors

4teen4 Pharmaceutical

4TEEN4 Pharmaceuticals develops precision medicine in critical care! Our therapy aims to restore cardiac and vascular function and reduce mortality in acute cardiovascular complications with limited effective therapies available.

 

Menarini Group

The Menarini Group is present in 140 countries around the world - from Europe to Asia, to Africa and the Middle East, from Central America to the US. Thanks to the contribution of over 17,000 employees, every year more than 500 million packs of drugs are produced at the Group's 18 manufacturing sites to improve patient health and well-being with a focus on cardiology, oncology, pneumology, inflammation, gastroenterology and AMR.

Transparency and Disclosures

In 2023, the Global Sepsis Alliance – initiator of World Sepsis Day – received total funding of approximately £322,360 (estimated €375,710). For a detailed breakdown, please refer to GSA’s annual financial accounts and reports, which are publicly available on the official Register of the Charity Commission for England and Wales. Of the total 2023 funding, GSA received €248,993 (estimated £213,636), or 66%, from corporate sponsors/industry. These funds were provided as educational grants or sponsorships in support of the World Sepsis Day Movement and World Sepsis Congress.  The remaining 34% of the total annual funding was generated through GSA’s membership fees, grants from non-profit and philanthropic organizations, and donations.

Become a Sponsor

If you are interested in becoming a sponsor or learning about our sponsorship guidelines, please get in touch. If you are a private person wanting to support World Sepsis Day, please sign the World Sepsis Declaration and consider donating.